Literature DB >> 9413156

Interleukin 18 enhances Fas ligand expression and induces apoptosis in Fas-expressing human myelomonocytic KG-1 cells.

T Ohtsuki1, M J Micallef, K Kohno, T Tanimoto, M Ikeda, M Kurimoto.   

Abstract

Interleukin-18 (IL-18) induces apoptosis in human myelomonocytic KG-1 cells as determined by agarose gel electrophoresis, and flow cytometry after propidium iodide (PI) staining. Apoptosis was detected 20 hours from the start of culture at concentrations of 100 ng/ml of the cytokine. Although IL-18 induces the production of large amounts of interferon gamma (IFN-gamma) by KG-1 cells, conditioned media could not induce apoptosis of fresh cells. The protein expressions of p53 and Fas ligand by KG-1 cells, which constitutively express the Fas antigen (CD95), were found to increase after exposure to IL-18 for 20 hours. Both Fas ligand and its receptor were found to be functional by in vitro assays on Fas-expressing target cells and an agonist anti-Fas antibody, respectively. In conclusion, IL-18 enhances the expression of Fas ligand by Fas-expressing KG-1 cells and induces apoptosis in the cells through a mechanism probably involving the Fas pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9413156

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  21 in total

1.  IL-18 mediates proapoptotic signaling in renal tubular cells through a Fas ligand-dependent mechanism.

Authors:  Hongji Zhang; Karen L Hile; Hiroshi Asanuma; Brian Vanderbrink; Ethan I Franke; Matthew T Campbell; Kirstan K Meldrum
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-20

2.  Elevated levels of soluble Fas (APO-1, CD95), soluble Fas ligand, and matrix metalloproteinase-3 in sera from patients with active untreated adult onset Still's disease.

Authors:  Der-Yuan Chen; Joung-Liang Lan; Fang-Ju Lin; Tsu-Yi Hsieh
Journal:  Clin Rheumatol       Date:  2006-09-14       Impact factor: 2.980

3.  Initiation of alcoholic fatty liver and hepatic inflammation with a specific recall immune response in alcohol-consuming C57Bl/6 mice.

Authors:  I I Slukvin; P J Boor; T R Jerrells
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

4.  DICER1/Alu RNA dysmetabolism induces Caspase-8-mediated cell death in age-related macular degeneration.

Authors:  Younghee Kim; Valeria Tarallo; Nagaraj Kerur; Tetsuhiro Yasuma; Bradley D Gelfand; Ana Bastos-Carvalho; Yoshio Hirano; Reo Yasuma; Takeshi Mizutani; Benjamin J Fowler; Shengjian Li; Hiroki Kaneko; Sasha Bogdanovich; Balamurali K Ambati; David R Hinton; William W Hauswirth; Razqallah Hakem; Charles Wright; Jayakrishna Ambati
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-27       Impact factor: 11.205

5.  Correlation between serum concentrations of soluble Fas (CD95/Apo-1) and IL-18 in patients with systemic lupus erythematosus.

Authors:  Maryam Sahebari; Zahra Rezaieyazdi; Mohammadreza J Nakhjavani; Mohammadreza Hatef; Mahmoud Mahmoudi; Saaid Akhlaghi
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

6.  IL-18, a product of choriodecidual cells, increases during premature rupture of membranes but fails to turn on the Fas-FasL-mediated apoptosis pathway.

Authors:  R Menon; S J Lombardi; S J Fortunato
Journal:  J Assist Reprod Genet       Date:  2001-05       Impact factor: 3.412

7.  Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients.

Authors:  U Coskun; N Gunel; B Sancak; E Onuk; M Bayram; A Cihan
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

8.  Interleukin 18 stimulates HIV type 1 in monocytic cells.

Authors:  L Shapiro; A J Puren; H A Barton; D Novick; R L Peskind; R Shenkar; Y Gu; M S Su; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

9.  Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis.

Authors:  N Calvani; H B Richards; M Tucci; G Pannarale; F Silvestris
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

10.  Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18.

Authors:  Ioannis Alagkiozidis; Andrea Facciabene; Carmine Carpenito; Fabian Benencia; Zdenka Jonak; Sarah Adams; Richard G Carroll; Phyllis A Gimotty; Rachel Hammond; Gwen-äel Danet-Desnoyers; Carl H June; Daniel J Powell; George Coukos
Journal:  J Transl Med       Date:  2009-12-10       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.